Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Malcolm Richardson

Showing results (11-20 of 61) with videos related to

Pageof 7
Sort By:
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Journal of Medical Microbiology|September 29, 2006
Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcusRiina Rautemaa, Peter Rusanen, Malcolm Richardson, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 10, 2009
Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003Nee Scze Khoo, Phillipa Van Essen, Malcolm Richardson, et al.
The Laryngoscope|April 13, 2007
Metalloproteinase function in chronic rhinosinusitis with nasal polyposisKatriina Kostamo, Taina Tervahartiala, Timo Sorsa, et al.
Scandinavian Journal of Infectious Diseases|July 25, 2008
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazoleRiina Rautemaa, Malcolm Richardson, Michael Pfaller, et al.
Clinical Oral Investigations|September 18, 2008
A novel method for sampling the microbiota from the oral mucosaPeter Rusanen, Emilia Siikala, Johanna Uittamo, et al.
The Lancet. Infectious Diseases|August 5, 2017
Emerging issues, challenges, and changing epidemiology of fungal disease outbreaksKaitlin Benedict, Malcolm Richardson, Snigdha Vallabhaneni, et al.
Microbiology Insights|October 28, 2021
Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal DiseaseMarjut Sakko, Riina Rautemaa-Richardson, Samuli Sakko, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2008
Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasisRiina Rautemaa, Malcolm Richardson, Michael A Pfaller, et al.
Thorax|August 24, 2016
Bagpipe lung; a new type of interstitial lung disease?Jenny King, Malcolm Richardson, Anne-Marie Quinn, et al.
Pageof 7

Showing results (11-20 of 61) with videos related to

Sort By:
Pageof 7
Annals of the New York Academy of Sciences|December 13, 2012
Preface for Advances Against AspergillosisKarl V Clemons, David S Perlin, Malcolm Richardson
Journal of Medical Microbiology|September 29, 2006
Optimal sampling site for mucosal candidosis in oral cancer patients is the labial sulcusRiina Rautemaa, Peter Rusanen, Malcolm Richardson, et al.
The Australian & New Zealand Journal of Obstetrics & Gynaecology|January 10, 2009
Effectiveness of prenatal diagnosis of congenital heart defects in South Australia: a population analysis 1999-2003Nee Scze Khoo, Phillipa Van Essen, Malcolm Richardson, et al.
The Laryngoscope|April 13, 2007
Metalloproteinase function in chronic rhinosinusitis with nasal polyposisKatriina Kostamo, Taina Tervahartiala, Timo Sorsa, et al.
Scandinavian Journal of Infectious Diseases|July 25, 2008
Reduction of fluconazole susceptibility of Candida albicans in APECED patients due to long-term use of ketoconazole and miconazoleRiina Rautemaa, Malcolm Richardson, Michael Pfaller, et al.
Clinical Oral Investigations|September 18, 2008
A novel method for sampling the microbiota from the oral mucosaPeter Rusanen, Emilia Siikala, Johanna Uittamo, et al.
The Lancet. Infectious Diseases|August 5, 2017
Emerging issues, challenges, and changing epidemiology of fungal disease outbreaksKaitlin Benedict, Malcolm Richardson, Snigdha Vallabhaneni, et al.
Microbiology Insights|October 28, 2021
Antibacterial Activity of 2-Hydroxyisocaproic Acid (HICA) Against Obligate Anaerobic Bacterial Species Associated With Periodontal DiseaseMarjut Sakko, Riina Rautemaa-Richardson, Samuli Sakko, et al.
Diagnostic Microbiology and Infectious Disease|July 4, 2008
Activity of amphotericin B, anidulafungin, caspofungin, micafungin, posaconazole, and voriconazole against Candida albicans with decreased susceptibility to fluconazole from APECED patients on long-term azole treatment of chronic mucocutaneous candidiasisRiina Rautemaa, Malcolm Richardson, Michael A Pfaller, et al.
Thorax|August 24, 2016
Bagpipe lung; a new type of interstitial lung disease?Jenny King, Malcolm Richardson, Anne-Marie Quinn, et al.
Pageof 7